Toxic Shock Syndrome

Toxic shock syndrome is a toxin-mediated shock state caused most often by Staphylococcus aureus or Streptococcus pyogenes, with mortality that can reach 30-80%. Early diagnosis is clinical, not criteria-driven: hypotension plus organ dysfunction should prompt a search for a hidden source infection and immediate treatment.

Recognizing Toxic Shock Syndrome

• Superantigen pathophysiology: TSS is driven by bacterial superantigens that bypass normal immune checkpoints, triggering massive cytokine release and rapid end-organ injury rather than a simple localized infection.
• Usual causative organisms: Staphylococcus aureus and Streptococcus pyogenes cause most cases, with staph now often tied to postoperative, postpartum, burn, or focal infections rather than tampon use alone.
• Classic but unreliable triad: Fever, hypotension, and a blanching diffuse red rash are the classic clues, but many patients present first with vomiting, diarrhea, myalgias, weakness, and chills instead.
• Criteria versus bedside diagnosis: CDC criteria differ for staph and strep TSS, but both hinge on hypotension and multisystem organ failure; the practical gaps between criteria and real-time diagnosis are worth hearing in the episode.
• Delayed desquamation finding: Desquamation of the palms and soles may not appear until 1-3 weeks into illness, making strict case definitions poorly suited to early emergency department recognition.
• Important clinical mimics: Adrenal insufficiency, septic shock, meningococcemia, and myocarditis can resemble TSS, especially when the presentation looks like a nonspecific viral illness tipping into shock.

Source Search and Early Treatment

• Hidden infection source: Once TSS is suspected, aggressively look for the source because toxin-producing infections can be deceptively quiet, with little redness, purulence, or localizing pain.
• Stealth soft tissue disease: Streptococcal TSS may accompany necrotizing fasciitis, myositis, cellulitis, or penetrating injury, especially when systemic toxicity seems out of proportion to the exam.
• Culture limitations: Blood cultures are frequently negative in staphylococcal TSS and miss a substantial share of streptococcal cases, so a negative culture should not reassure you early.
• High-risk ED scenarios: Think TSS in a young patient with viral-like symptoms and septic shock, or in any patient whose vitals and overall toxicity feel far worse than the chief complaint.
• Immediate management priority: Treatment starts with source control and early therapy rather than waiting for formal criteria to be met. We get into the bedside approach in the chapter.